These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2470304)

  • 1. Keratinocytes produce a lymphocyte inhibitory factor which is partially reversible by an antibody to transforming growth factor-beta.
    Nickoloff BJ
    Ann N Y Acad Sci; 1988; 548():312-20. PubMed ID: 2470304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors.
    Nickoloff BJ; Mitra RS; Riser BL; Dixit VM; Varani J
    Am J Pathol; 1988 Sep; 132(3):543-51. PubMed ID: 2458044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environment-dependent growth inhibition of human epidermal keratinocytes by recombinant human transforming growth factor-beta.
    Rollins BJ; O'Connell TM; Bennett G; Burton LE; Stiles CD; Rheinwald JG
    J Cell Physiol; 1989 Jun; 139(3):455-62. PubMed ID: 2472411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal G1-chalone and transforming growth factor-beta are two different endogenous inhibitors of epidermal cell proliferation.
    Richter KH; Schnapke R; Clauss M; Fürstenberger G; Hinz D; Marks F
    J Cell Physiol; 1990 Mar; 142(3):496-504. PubMed ID: 1968903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1.
    Inge TH; Hoover SK; Susskind BM; Barrett SK; Bear HD
    Cancer Res; 1992 Mar; 52(6):1386-92. PubMed ID: 1531782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of transforming growth factor beta in the maturation of human epidermal keratinocytes.
    Mansbridge JN; Hanawalt PC
    J Invest Dermatol; 1988 Mar; 90(3):336-41. PubMed ID: 2450142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth modulation of mouse keratinocytes by transforming growth factors.
    Coffey RJ; Sipes NJ; Bascom CC; Graves-Deal R; Pennington CY; Weissman BE; Moses HL
    Cancer Res; 1988 Mar; 48(6):1596-602. PubMed ID: 2449957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta 1 localization in normal and psoriatic epidermal keratinocytes in situ.
    Kane CJ; Knapp AM; Mansbridge JN; Hanawalt PC
    J Cell Physiol; 1990 Jul; 144(1):144-50. PubMed ID: 1694857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of transforming growth factor-beta (TGF beta) isoforms and TGF beta type II receptor messenger ribonucleic acid and protein, and the effect of TGF beta s on endometrial stromal cell growth and protein degradation in vitro.
    Tang XM; Zhao Y; Rossi MJ; Abu-Rustum RS; Ksander GA; Chegini N
    Endocrinology; 1994 Jul; 135(1):450-9. PubMed ID: 8013384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of TGF-alpha and TGF-beta by cultured keratinocytes, skin and oral squamous cell carcinomas--potential autocrine regulation of normal and malignant epithelial cell proliferation.
    Partridge M; Green MR; Langdon JD; Feldmann M
    Br J Cancer; 1989 Oct; 60(4):542-8. PubMed ID: 2478181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies of the role of transforming growth factor-beta in human B cell function.
    Kehrl JH; Taylor AS; Delsing GA; Roberts AB; Sporn MB; Fauci AS
    J Immunol; 1989 Sep; 143(6):1868-74. PubMed ID: 2550546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of androgen-inducible TGF-beta1 derived from dermal papilla cells as a key mediator in androgenetic alopecia.
    Inui S; Fukuzato Y; Nakajima T; Yoshikawa K; Itami S
    J Investig Dermatol Symp Proc; 2003 Jun; 8(1):69-71. PubMed ID: 12894997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The production of transforming growth factor-beta in the porcine ovary and its secretion in vitro.
    Gangrade BK; May JV
    Endocrinology; 1990 Nov; 127(5):2372-80. PubMed ID: 2226322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of growth and differentiation of human keratinocytes by type beta transforming growth factor and epidermal growth factor.
    Reiss M; Sartorelli AC
    Cancer Res; 1987 Dec; 47(24 Pt 1):6705-9. PubMed ID: 2445478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of growth factors on the proliferation of human keratinocytes and fibroblasts in vitro.
    Kim DS; Korting HC; Schäfer-Korting M
    Pharmazie; 1998 Jan; 53(1):51-7. PubMed ID: 9476258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rat thecal/interstitial cells secrete a transforming growth factor-beta-like factor that promotes growth and differentiation in rat granulosa cells.
    Bendell JJ; Dorrington J
    Endocrinology; 1988 Aug; 123(2):941-8. PubMed ID: 3135176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.
    Shipley GD; Pittelkow MR; Wille JJ; Scott RE; Moses HL
    Cancer Res; 1986 Apr; 46(4 Pt 2):2068-71. PubMed ID: 2418960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing antibodies against transforming growth factor beta potentiate the proliferation of Ki-1 positive lymphoma cells. Further evidence for negative autocrine regulation by transforming growth factor beta.
    Newcom SR; Tagra KK; Kadin ME
    Am J Pathol; 1992 Mar; 140(3):709-18. PubMed ID: 1312308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased production of transforming growth factor-beta 2 from cultured human retinal pigment epithelial cells by photocoagulation.
    Matsumoto M; Yoshimura N; Honda Y
    Invest Ophthalmol Vis Sci; 1994 Dec; 35(13):4245-52. PubMed ID: 8002244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoregulation by eicosanoids of human Kupffer cell secretory products. A study of interleukin-1, interleukin-6, tumor necrosis factor-alpha, transforming growth factor-beta, and nitric oxide.
    Roland CR; Goss JA; Mangino MJ; Hafenrichter D; Flye MW
    Ann Surg; 1994 Apr; 219(4):389-99. PubMed ID: 8161265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.